Cargando…
Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation
The immune receptor NKG2D is predominantly expressed on NK cells and T cell subsets and confers anti-tumor activity. According to the current paradigm, immune surveillance is counteracted by soluble ligands shed into the microenvironment, which down-regulate NKG2D receptor expression. Here, we analy...
Autores principales: | Vyas, Maulik, Reinartz, Silke, Hoffmann, Nathalie, Reiners, Katrin S., Lieber, Sonja, Jansen, Julia M., Wagner, Uwe, Müller, Rolf, von Strandmann, Elke Pogge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599084/ https://www.ncbi.nlm.nih.gov/pubmed/28932639 http://dx.doi.org/10.1080/2162402X.2017.1339854 |
Ejemplares similares
-
Soluble NKG2D ligands impair CD8(+) T cell antitumor function dependent of NKG2D downregulation in neuroblastoma
por: Zhang, Yi, et al.
Publicado: (2023) -
The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
por: Tan, Ge, et al.
Publicado: (2023) -
CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells
por: Sauer, M, et al.
Publicado: (2017) -
Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns
por: Haik, Josef, et al.
Publicado: (2015) -
New prospects on the NKG2D/NKG2DL system for oncology
por: Ullrich, Evelyn, et al.
Publicado: (2013)